{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:46:48Z","timestamp":1778395608119,"version":"3.51.4"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Objective Identifying patients who are medication nonpersistent (fail to refill in a timely manner) is important for healthcare operations and research. However, consistent methods to detect nonpersistence using electronic pharmacy records are presently lacking. We developed and validated a nonpersistence algorithm for chronically used medications.<\/jats:p>\n               <jats:p>Materials and Methods Refill patterns of adult diabetes patients (n\u2009=\u200914,349) prescribed cardiometabolic therapies were studied. We evaluated various grace periods (30-300 days) to identify medication nonpersistence, which is defined as a gap between refills that exceeds a threshold equal to the last days\u2019 supply dispensed plus a grace period plus days of stockpiled medication. Since data on medication stockpiles are typically unavailable for ongoing users, we compared nonpersistence to rates calculated using algorithms that ignored stockpiles.<\/jats:p>\n               <jats:p>Results When using grace periods equal to or greater than the number of days\u2019 supply dispensed (i.e., at least 100 days), this novel algorithm for medication nonpersistence gave consistent results whether or not it accounted for days of stockpiled medication. The agreement (Kappa coefficients) between nonpersistence rates using algorithms with versus without stockpiling improved with longer grace periods and ranged from 0.63 (for 30 days) to 0.98 (for a 300-day grace period).<\/jats:p>\n               <jats:p>Conclusions Our method has utility for health care operations and research in prevalent (ongoing) and new user cohorts. The algorithm detects a subset of patients with inadequate medication-taking behavior not identified as primary nonadherent or secondary nonadherent. Healthcare systems can most comprehensively identify patients with short- or long-term medication underutilization by identifying primary nonadherence, secondary nonadherence, and nonpersistence.<\/jats:p>","DOI":"10.1093\/jamia\/ocv054","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T00:50:54Z","timestamp":1434415854000},"page":"957-961","source":"Crossref","is-referenced-by-count":39,"title":["An algorithm to identify medication nonpersistence using electronic pharmacy databases"],"prefix":"10.1093","volume":"22","author":[{"given":"Melissa M","family":"Parker","sequence":"first","affiliation":[{"name":"Kaiser Permanente, Division of Research, Oakland, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard H","family":"Moffet","sequence":"additional","affiliation":[{"name":"Kaiser Permanente, Division of Research, Oakland, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyce","family":"Adams","sequence":"additional","affiliation":[{"name":"Kaiser Permanente, Division of Research, Oakland, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J","family":"Karter","sequence":"additional","affiliation":[{"name":"Kaiser Permanente, Division of Research, Oakland, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,6,13]]},"reference":[{"issue":"17","key":"2020110613040192000_ocv054-B1","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/archinte.166.17.1842","article-title":"Impact of medication therapy discontinuation on mortality after myocardial infarction","volume":"166","author":"Ho","year":"2006","journal-title":"Arch Intern Med."},{"issue":"3","key":"2020110613040192000_ocv054-B2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCOUTCOMES.109.887620","article-title":"Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes","volume":"3","author":"Lipska","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"2020110613040192000_ocv054-B3","doi-asserted-by":"crossref","first-page":"d4094","DOI":"10.1136\/bmj.d4094","article-title":"Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care","volume":"343","author":"Rodriguez","year":"2011","journal-title":"BMJ."},{"issue":"6","key":"2020110613040192000_ocv054-B4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/ard.2010.142455","article-title":"Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study","volume":"70","author":"De Vera","year":"2011","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"2020110613040192000_ocv054-B5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s11606-014-2845-6","article-title":"Associations between antidepressant adherence and shared decision-making, patient-provider trust, and communication among adults with diabetes: diabetes study of Northern California (DISTANCE)","volume":"29","author":"Bauer","year":"2014","journal-title":"J Gen Intern Med."},{"issue":"5","key":"2020110613040192000_ocv054-B6","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.1475-6773.2009.00989.x","article-title":"New prescription medication gaps: a comprehensive measure of adherence to new prescriptions","volume":"44","author":"Karter","year":"2009","journal-title":"Health Serv Res."},{"issue":"9","key":"2020110613040192000_ocv054-B7","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.clinthera.2006.09.021","article-title":"Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization","volume":"28","author":"Caetano","year":"2006","journal-title":"Clin Ther."},{"issue":"8","key":"2020110613040192000_ocv054-B8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medication adherence and persistence using automated databases","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"7","key":"2020110613040192000_ocv054-B9","first-page":"449","article-title":"Estimating medication persistency using administrative claims data","volume":"11","author":"Sikka","year":"2005","journal-title":"Am J Manag Care."},{"issue":"8 Suppl 3","key":"2020110613040192000_ocv054-B10","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","article-title":"Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases","volume":"51","author":"Raebel","year":"2013","journal-title":"Med Care."},{"issue":"1","key":"2020110613040192000_ocv054-B11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health."},{"issue":"10","key":"2020110613040192000_ocv054-B12","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/heartjnl-2013-304960","article-title":"Maintenance of statin use over 3 years following acute coronary syndromes: a national data linkage study (ANZACS-QI-2)","volume":"100","author":"Grey","year":"2014","journal-title":"Heart."},{"issue":"(8","key":"2020110613040192000_ocv054-B13","first-page":"814","article-title":"A general method of compliance assessment using centralized pharmacy records","volume":"26","author":"Steiner","year":"1988","journal-title":"Description and validation. Med Care."},{"issue":"1","key":"2020110613040192000_ocv054-B14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jclinepi.2005.05.005","article-title":"Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation","volume":"59","author":"Van Wijk","year":"2006","journal-title":"J Clin Epidemiol."},{"issue":"1","key":"2020110613040192000_ocv054-B15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ahj.2006.10.018","article-title":"Comparison of measures of medication persistency using a prescription drug database","volume":"153","author":"Hudson","year":"2007","journal-title":"Am Heart J."},{"issue":"2","key":"2020110613040192000_ocv054-B16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/pds.1693","article-title":"Estimating the effect of current, previous and never use of drugs in studies based on prescription registries","volume":"18","author":"Nielsen","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"2","key":"2020110613040192000_ocv054-B17","first-page":"95","article-title":"Recent trends in the dispensing of 90-day-supply prescriptions at retail pharmacies: implications for improved convenience and access","volume":"4","author":"Liberman","year":"2011","journal-title":"Am Health Drug Benefits."},{"issue":"2","key":"2020110613040192000_ocv054-B18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7812\/TPP\/11-148","article-title":"Out-of-plan pharmacy use by members of a managed care organization","volume":"16","author":"Delate","year":"2012","journal-title":"Perm J."},{"issue":"1","key":"2020110613040192000_ocv054-B19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ije\/dyn040","article-title":"Cohort Profile: The Diabetes Study of Northern California (DISTANCE)\u2013objectives and design of a survey follow-up study of social health disparities in a managed care population","volume":"38","author":"Moffet","year":"2008","journal-title":"Int J Epidemiol."},{"issue":"11","key":"2020110613040192000_ocv054-B20","first-page":"598","article-title":"Glycemic response to newly initiated diabetes therapies","volume":"13","author":"Karter","year":"2007","journal-title":"Am J Manag Care."},{"issue":"7","key":"2020110613040192000_ocv054-B21","first-page":"352","article-title":"Screening electronic veterans' health records for medication discontinuation","volume":"18","author":"Rector","year":"2012","journal-title":"Am J Manag Care."},{"issue":"Part 4","key":"2020110613040192000_ocv054-B22","first-page":"707","article-title":"Validation of methods for identifying discontinuation of treatment from prescription data","volume":"59","author":"Nielsen","year":"2010","journal-title":"Appl Statist."},{"issue":"20","key":"2020110613040192000_ocv054-B23","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/jama.2013.4638","article-title":"Medication nonadherence: a diagnosable and treatable medical condition","volume":"309","author":"Marcum","year":"2013","journal-title":"JAMA."},{"issue":"8","key":"2020110613040192000_ocv054-B24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.167.8.847","article-title":"Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use","volume":"167","author":"Brookhart","year":"2007","journal-title":"Arch Intern Med."},{"key":"2020110613040192000_ocv054-B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9343(01)00742-2","article-title":"Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry*","volume":"111","author":"Karter","year":"2001","journal-title":"Am J Med."},{"key":"2020110613040192000_ocv054-B26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2105\/AJPH.82.5.703","article-title":"Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology","volume":"82","author":"Krieger","year":"1992","journal-title":"Am J Public Health."},{"key":"2020110613040192000_ocv054-B27","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2105\/AJPH.72.8.829","article-title":"Characteristics of patients referred for treatment of end-stage renal disease in a defined population","volume":"72","author":"Hiatt","year":"1982","journal-title":"Am J Public Health."},{"issue":"3","key":"2020110613040192000_ocv054-B28","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.5600\/mmrr.002.03.A04","article-title":"Medication days' supply, adherence, wastage, and cost among chronic patients in Medicaid","volume":"2","author":"Taitel","year":"2012","journal-title":"Medicare Medicaid Res Rev."},{"issue":"7","key":"2020110613040192000_ocv054-B29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mlr.0000129496.05898.02","article-title":"The concordance of self-report with other measures of medication adherence: a summary of the literature","volume":"42","author":"Garber","year":"2004","journal-title":"Med Care."},{"key":"2020110613040192000_ocv054-B30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2261-6-48","article-title":"Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease","volume":"6","author":"Ho","year":"2006","journal-title":"BMC Cardiovasc Disord."},{"issue":"2","key":"2020110613040192000_ocv054-B31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction","volume":"297","author":"Rasmussen","year":"2007","journal-title":"JAMA."},{"issue":"4","key":"2020110613040192000_ocv054-B32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ahj.2007.12.011","article-title":"Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease","volume":"155","author":"Ho","year":"2008","journal-title":"Am Heart J."},{"issue":"9","key":"2020110613040192000_ocv054-B33","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/00005650-199909000-00002","article-title":"Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy","volume":"37","author":"Choo","year":"1999","journal-title":"Med Care."},{"issue":"5","key":"2020110613040192000_ocv054-B34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0895-4356(97)00040-1","article-title":"Validation of pharmacy records in drug exposure assessment","volume":"50","author":"Lau","year":"1997","journal-title":"J Clin Epidemiol."}],"container-title":["Journal of the American Medical Informatics Association"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/22\/5\/957\/34145886\/ocv054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/22\/5\/957\/34145886\/ocv054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T19:02:04Z","timestamp":1604689324000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamia\/article\/22\/5\/957\/930718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,13]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,6,13]]},"published-print":{"date-parts":[[2015,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jamia\/ocv054","relation":{},"ISSN":["1527-974X","1067-5027"],"issn-type":[{"value":"1527-974X","type":"electronic"},{"value":"1067-5027","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,9]]},"published":{"date-parts":[[2015,6,13]]}}}